$Bio-Path Holdings (BPTH.US)$Bio-Path Holdings Receives Patent No. 17/339,366 Titled, "P-ethoxy Nucleic Acids for STAT3 Inhibition." From United States Patent And Trademark Office
2
Report
SmellyStipes
:
how do you get these news alerts so quick? how do you know which ones to jump on?
Trytosaveabit
OPSmellyStipes
:
Theres different breaking news sites! as far as jumping in. Practice and knowing how to read the chart / volume! Also theres never a guarantee when you get in! But risk management and knowing that a loss is possible but limit it if you’re wrong
$Bio-Path Holdings (BPTH.US)$ Bio-Path Holdings Expands Global Patent Portfolio Thursday, 13th February at 4:01 pm HOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on th...
$Bio-Path Holdings (BPTH.US)$The new share offerring is 0.769 per shares. Lol, now the pre-market price is cheaper than the share offerring.
Report
No comment yet
Sign in to post a comment
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Bio-Path Holdings Stock Forum
#pleaseDontScareMe
Bio-Path Holdings Expands Global Patent Portfolio
Thursday, 13th February at 4:01 pm
HOUSTON, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer and obesity drugs, today announced the receipt of newly issued patents in the United States and New Zealand, and updated investors on th...
Breakthrough Cancer Trial Results: Bio-Path's Dual Success in Solid Tumors and AML Remission
No comment yet